Haleon Pakistan Limited (PSX:HALEON)

Pakistan flag Pakistan · Delayed Price · Currency is PKR
757.28
-7.33 (-0.96%)
At close: Apr 27, 2026
0.17%
Market Cap 88.45B
Revenue (ttm) 43.11B
Net Income (ttm) 6.37B
Shares Out 117.05M
EPS (ttm) 54.45
PE Ratio 13.88
Forward PE 13.04
Dividend 30.00 (3.96%)
Ex-Dividend Date Apr 21, 2026
Volume 34,623
Average Volume 92,620
Open 760.00
Previous Close 764.61
Day's Range 752.00 - 769.00
52-Week Range 653.14 - 1,010.00
Beta 0.50
RSI 49.91
Earnings Date Apr 29, 2026

About Haleon Pakistan

Haleon Pakistan Limited engages in the manufacture, marketing, and sale of consumer healthcare products in Pakistan, rest of Asia, Africa, Australia, North America, the Middle East, and Europe. The company offers oral health, pain relief, wellness and nutrition, and respiratory health products, as well as over-the-counter pharmaceutical products. It sells its products primarily under the Panadol, CaC-1000 Plus, Sensodyne, paradontax, T-Day, ENO, Hydrozole, Qalsium-D, and Voltral Emulgel brands. The company also exports its products to Vietnam, ... [Read more]

Industry Pharmaceutical Preparations
Founded 2015
Employees 451
Stock Exchange Pakistan Stock Exchange
Ticker Symbol HALEON
Full Company Profile

Financial Performance

In 2025, Haleon Pakistan's revenue was 43.11 billion, an increase of 15.86% compared to the previous year's 37.21 billion. Earnings were 6.37 billion, an increase of 39.21%.

Financial Statements

News

There is no news available yet.